Supernus Pharmaceuticals reported $734.15M in Current Assets for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Ani Pharmaceuticals ANIP:US USD 344.26M 34.88M
Aurora Cannabis Inc ACB:CN CAD 542.79M 139.04M
Canopy Growth Corp WEED:CN CAD 1.17B 365.26M
Cara Therapeutics CARA:US USD 168.91M 17.87M
Corcept Therapeutics CORT:US USD 499.25M 46.85M
Eisai 4523:JP JPY 610.12B 24.74B
Endo International Ordinary Shares ENDP:US USD 2.05B 145.74M
Horizon Pharma HZNP:US USD 3.65B 240.83M
Lannett LCI:US USD 250.53M 14.13M
Pacira Pharmaceuticals PCRX:US USD 498.33M 35.08M
Perrigo Ordinary Shares PRGO:US USD 2.72B 136.6M
Revance Therapeutics RVNC:US USD 374.73M 40.87M
Supernus Pharmaceuticals SUPN:US USD 734.15M 70.26M
Teva Pharmaceutical Industries TEVA:US USD 12.05B 598M
United Therapeutics UTHR:US USD 3.38B 323.9M
Xeris Pharmaceuticals Inc XERS:US USD 186.82M 37.9M